Gerhards M F, den Hartog D, Rauws E A, van Gulik T M, González González D, Lameris J S, de Wit L T, Gouma D J
Department of Surgery, Academic Medical Center, University of Amsterdam, The Netherlands.
Eur J Surg. 2001 Apr;167(4):274-80. doi: 10.1080/110241501300091444.
To find out how patients fared after palliative endoscopic biliary drainage for inoperable hilar cholangiocarcinoma.
Retrospective study.
University hospital, the Netherlands.
Between 1992 and 1999, 41 patients who were referred for resection had tumours that were considered unresectable after additional investigations, including an exploratory laparotomy in 16 patients. In all patients, biliary drainage was established by endoscopic retrograde cholangiography (ERCP) and insertion of endoprostheses. Twelve patients also had percutaneous transhepatic biliary drainage (PTBD).
The patients who did not have an exploratory laparotomy had fewer complications (1/25) than those who had explorations (4/16). All patients in both groups had one or more long-term complications during follow-up, of which cholangitis, jaundice, and abdominal pain were the most often recorded. In 32 patients, endoprostheses had to be replaced, a mean of 4 times. Median survival was 9 months, with no significant difference between the groups (8 and 11 months). Adjuvant radiotherapy had no influence on survival.
The patients in this series had relatively long survival times, during which they had a substantial number of complications predominantly related to biliary drainage. Because biliary-enteric bypass operations result in effective relief of symptoms and excellent palliation, we suggest that when an exploration is done for patients with type III and IV tumours, a bypass should be made.
了解无法手术切除的肝门部胆管癌患者接受姑息性内镜下胆道引流后的病情转归。
回顾性研究。
荷兰的大学医院。
1992年至1999年间,41例因拟行切除术而转诊的患者,经包括16例行剖腹探查术在内的进一步检查后,肿瘤被认为无法切除。所有患者均通过内镜逆行胆管造影(ERCP)及置入内支架建立胆道引流。12例患者还接受了经皮经肝胆道引流(PTBD)。
未行剖腹探查术的患者并发症较少(1/25),而行剖腹探查术的患者并发症较多(4/16)。两组所有患者在随访期间均出现一种或多种长期并发症,其中胆管炎、黄疸和腹痛最为常见。32例患者的内支架需要更换,平均更换4次。中位生存期为9个月,两组之间无显著差异(8个月和11个月)。辅助放疗对生存期无影响。
本系列患者生存期相对较长,在此期间出现大量主要与胆道引流相关的并发症。由于胆肠吻合术能有效缓解症状并实现良好的姑息治疗效果,我们建议对Ⅲ型和Ⅳ型肿瘤患者进行探查时应行胆肠吻合术。